Annals of the Rheumatic Diseases (@eular

Annals of the Rheumatic Diseases

5,783 posts

Annals of the Rheumatic Diseases

@eular_ARD

Annals of the Rheumatic Diseases (#1 research journal in Rheumatology). High quality, peer reviewed research.

eular.org/eular-journals

Joined April 2010

Annals of the Rheumatic Diseases
@eular_ARD
Oct 13, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update 🔴 HCQ for all 5 mg/kg/day 🔴 GC as ‘bridging therapy’ or maintenance ≤ 5 mg/day 🔴 Prompt initiation of immunosuppressive and/or biological agents @eular_org 👉 bit.ly/45ulfyD
78K
Annals of the Rheumatic Diseases
@eular_ARD
Feb 2, 2022
🚨 # 2022 ACR/EULAR classification criteria for granulomatosis with polyangiitis 1️⃣sensitivity 93% 2️⃣specificity 94% bit.ly/34vKRBl
Annals of the Rheumatic Diseases
@eular_ARD
Jun 3, 2023
2023 SLE Recommendations 🔹Lower GC dose (5 mg instead of 7.5) 🔹 Early use of biologics for corticosparing 🔹 Cyclophosphamide if life-threatening 🔹 MMF: new in hemato manif 🔹Lupus nephritis: VCL vs BEL??? 🔹Maintain trt for 3 years then taper, except HCQ #EULAR2023 NZ
75K
Annals of the Rheumatic Diseases
@eular_ARD
Oct 13, 2023
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update ▶️ Lupus proliferative Nephritis 🔴 Low-dose IV cyclophosphamide or MMF + glucocorticoids 🔴 Combination with belimumab or calcineurin inhib. should be considered. 👉 bit.ly/45ulfyD
16K
Annals of the Rheumatic Diseases
@eular_ARD
Jun 1, 2024
🌟 B-cell depletion in autoimmune diseases 🔷 Review 🔷Current therapeutic strategies to deplete B cells in order to ameliorate or potentially even cure autoimmune disease 🔗 bit.ly/3RwAWBx
18K
Annals of the Rheumatic Diseases
@eular_ARD
Nov 4, 2023
🤩All you want to know about #JAKinhibitors is in this #review❗ ⛳ #efficacy 🛡️ #safety 🎯 #selectivity 🔢 1^/2^#generation 👉 new paradigm for the treatment of #inflammatorydiseases #RA #PsA #SpA #psoriasis #IBD #AD 🔗bit.ly/3QKL2Pa @DanielAletaha @MichaelBonell10
18K
Annals of the Rheumatic Diseases
@eular_ARD
Feb 6, 2022
#EULAR 2021 updated viewpoints on #SARS-CoV-2 # vaccination in patients with RMDs: a guidance to answer patients’ questions 😷 bit.ly/3JbYcy1
Annals of the Rheumatic Diseases
@eular_ARD
Jun 2, 2023
Treatment algorithms for the treatment of Behcet’s disease according to organ involvement (Part 1) Pr. Gulen Hatemi #EULAR2023 NZ
15K
Annals of the Rheumatic Diseases
@eular_ARD
May 24, 2024
🙌Novel auto-antibody in #SSc 👉Anti-anti-PRMT5 antibodies ✅️correlated with progression in skin and lung ✅️distinguished SSc from healthy, lupus and Sjögren’s syndrom ✅️induced SSc-like manifestations in mice ard.bmj.com/content/early/…
18K
Annals of the Rheumatic Diseases
@eular_ARD
Feb 2, 2022
🚨 # 2022 ACR/EULAR classification criteria for Rheumatology classification criteria for microscopic polyangiitis 1️⃣sensitivity 91% 2️⃣specificity 94% bit.ly/3AVW8qP
Annals of the Rheumatic Diseases
@eular_ARD
Feb 2, 2022
🚨 # 2022 ACR/EULAR classification criteria for Eosinophilic Granulomatosis with Polyangiitis 1️⃣ sensitivity 85% 2️⃣ specificity 99% bit.ly/3okkvcB
Annals of the Rheumatic Diseases
@eular_ARD
Oct 16, 2023
Check out our latest editorial revisiting the latest evidence on #glucocorticoid treatment in #rheumatic diseases: ▶️ mechanisms of action ▶️ adverse events (including cardiovascular and infection) ▶️ clinical studies ▶️ benefit/harm risk ▶️ tapering 🔗 ard.bmj.com/content/early/…
30K
Annals of the Rheumatic Diseases
@eular_ARD
Jun 13, 2024
#VEXAS can also affect women and the clinical spectrum is similar to male patients #EULAR2024 MP
9.1K
Annals of the Rheumatic Diseases
@eular_ARD
Sep 29, 2024
🚨New #EULAR/#PReS recommendations for the diagnosis and treatment of #Still‘s Disease🚨in children 🧒 👦and adults 👩 👨 #recommendation #guideline #autoinflammation 🔗 ard.bmj.com/content/early/…
9K